Amicogen Corrects Audit Report: Net Assets and Net Loss Increased Due to Subsidiary Impairment Error

Correction of audit report for FY ended Dec 31, 2025: Financial statements restated due to error in impairment loss on subsidiary investments.
Impact: 2025 net assets decreased by KRW 9.913 billion, net loss increased by KRW 2.268 billion; 2024 net assets decreased by KRW 7.645 billion, net loss increased by KRW 7.645 billion.
Auditor (Samduk Accounting Corp.) reissued unqualified opinion with emphasis of matter.
As of Dec 31, 2025: Total assets KRW 197.471 billion, total liabilities KRW 86.336 billion, total equity KRW 111.136 billion, net loss KRW 23.485 billion (previously KRW 21.217 billion), EPS loss KRW 425 (previously KRW 384).
Debt ratio 77.68%, net debt ratio 59.47%.
Subsequent event: Rights offering completed (14,925,374 shares, raised KRW 17.373 billion, listing on Feb 26, 2026).